Melodyn

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Melodyn

Property Description
Active Ingredient Meloxicam
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID)
Origin Synthetic, Oxicam Derivative
Available Forms Tablet, Capsule, Oral Suspension, Intravenous Solution
General Purpose Anti-inflammatory and Analgesic (Pain Relief)

What Type of Medicine is Melodyn and What is its Composition?

Melodyn is the trade name for a synthetic pharmaceutical preparation whose sole active substance is Meloxicam. This compound belongs to the overarching pharmacological class known as Nonsteroidal Anti-inflammatory Drugs (NSAIDs), a designation used for systemic medicines that work throughout the entire body. Meloxicam is specifically an oxicam derivative and is characterized as a preferential inhibitor of the cyclo-oxygenase-2 (COX-2) enzyme. This feature is clinically recognized for providing a targeted approach to managing inflammatory symptoms and contributes to its use in long-term conditions like arthritis.

Forms of Melodyn and General Purpose

Melodyn (Meloxicam) is produced in multiple preparations for internal use, offering flexibility across various delivery routes. These forms include conventional oral forms such as tablets, capsules, and oral suspension, as well as an intravenous solution for injection. The general purpose of this systemic medication is to achieve simultaneous anti-inflammatory and analgesic effects. Meloxicam is recognized globally as an essential medicine for conditions where inflammation and pain are key factors. By modulating the body's pain-inducing chemical production, the drug's fundamental function is to temper swelling, mitigate tenderness, and alleviate generalized discomfort associated with inflammatory processes.

What side effects are possible with Melodyn?

Possible Side Effects and Safety Information

The overall safety profile of Melodyn (nirsevimab) is generally favorable, with the majority of adverse events reported in clinical trials being mild to moderate in severity.

Adverse Reactions Summary

Classification System-Organ Class Adverse Reaction Frequency
Most Common General / Local Injection site reactions (e.g., pain, swelling) Uncommon (0.1% to 1%)
Most Common Skin / Systemic Rash Uncommon (0.1% to 1%)
Most Common General Pyrexia (fever) Uncommon (0.1% to 1%)
Serious Immune System Hypersensitivity reactions (including anaphylaxis) Not Known (Post-marketing)

The frequency classification (Uncommon) is based on the official regulatory reporting system derived from clinical trials, while serious hypersensitivity is noted as a risk for the drug class, observed in post-marketing reports for nirsevimab (Not Known frequency).

Clinically Significant Safety Considerations

Contraindication: Melodyn is contraindicated in individuals with a history of serious hypersensitivity reactions, including anaphylaxis, to the active substance or any of the excipients.

Warnings and Precautions:

  • Hypersensitivity: Serious hypersensitivity reactions, including anaphylaxis, have been reported. Appropriate treatment and monitoring should be available at the time of administration.
  • Bleeding Disorders: As with any intramuscular injection, Melodyn should be administered with caution to infants and children with thrombocytopenia, any coagulation disorder, or to those receiving anticoagulation therapy, due to the risk of bruising or bleeding at the injection site.

Population-Specific Notes

The safety and efficacy have been established in infants born during or entering their first Respiratory Syncytial Virus (RSV) season, and in some children up to 24 months of age who remain vulnerable to severe RSV disease. Safety data are limited in extremely preterm infants and those with certain underlying conditions, such as those undergoing cardiopulmonary bypass or extracorporeal membrane oxygenation.

Overdose and Emergency Response

The official regulatory profile for Melodyn (Meloxicam) overdose defines both common and potentially life-threatening manifestations, strictly guiding the need for emergency medical intervention.

Documented Overdose Manifestations

Common signs following an acute overdose, which are generally reversible with supportive care, include lethargy, drowsiness, nausea, vomiting, and epigastric pain. Regulators also document the risk of gastrointestinal bleeding.

Severe Outcomes and Required Emergency Actions

Immediate medical attention is mandated for any suspected overdose or the onset of severe systemic effects, as these are classified as signs of severe poisoning.

System Affected Severe Manifestations (Documented)
Systemic/CNS Respiratory depression, Coma, Convulsions
Cardiovascular Hypertension, Cardiovascular collapse, Cardiac arrest
Organ Function Acute renal failure, Hepatic dysfunction
Hypersensitivity Anaphylactoid reactions

The regulatory guidance emphasizes that no specific antidote is known for Meloxicam overdose. Management requires symptomatic and supportive care. Documented procedural interventions include the administration of activated charcoal (recommended in early post-ingestion) and the use of Cholestyramine, which is known to accelerate the clearance of the drug.

Therapeutic Uses of Melodyn

What Melodyn Treats: Main Uses and Benefits

Melodyn is generally used for the long-term symptomatic management of chronic inflammatory joint diseases, which are conditions where the functional stability may become affected. This may include Osteoarthritis (OA) and Rheumatoid Arthritis (RA) in adults, Ankylosing Spondylitis (AS), and the symptomatic relief of Juvenile Idiopathic Arthritis (JIA) in pediatric patients. The primary benefit within its approved therapeutic domain is to help address symptom clusters that may become intense or disruptive, such as joint pain, localized swelling, and stiffness.


The medication is commonly used across conditions characterized by periods of heightened symptoms involving the musculoskeletal system, including specific back pain syndromes. Applied in clinical settings that involve acute or unstable symptom patterns, such as managing significant pain associated with acute flares or following certain procedures, it provides supportive relief when symptoms interfere with routine activities.

“The therapeutic goal is symptomatic management, aiming to support the patient during difficult episodes by easing discomfort and contributing to improved day-to-day comfort.”

It may assist with supporting functional stability and contributes to easing the overall symptom load, helping patients cope more steadily with symptom fluctuations.


Quick Fact: Relief for Inflammatory Joint Discomfort Melodyn plays a role in managing systemic inflammatory symptoms, which can assist with maintaining comfort and supports the patient during symptomatic periods.

Eligibility and Restrictions for Use

Who Can and Cannot Use Melodyn?

Eligibility for Melodyn (Meloxicam) is strictly governed by regulatory authorities, with formal rules defining approved populations, conditional use, and absolute contraindications.


Populations for Whom Melodyn is Contraindicated

Melodyn must not be used by individuals with certain pre-existing conditions or circumstances, as these represent absolute exclusions from use:

  • Hypersensitivity: Known allergy to Meloxicam, Aspirin, or any other NSAID.
  • GI Bleeding/Ulcers: Active or a history of recurrent gastrointestinal hemorrhage or peptic ulceration.
  • Severe Organ Impairment: Severe, non-dialyzed renal impairment, severely impaired liver function, or severe, uncontrolled heart failure.
  • Cardiovascular Surgery: Treatment of pain related to Coronary Artery Bypass Graft (CABG) surgery.
  • Pregnancy: Use is strictly prohibited during the third trimester of pregnancy.

Age and Condition-Based Restrictions

Melodyn is approved for adults with Osteoarthritis and Rheumatoid Arthritis. In pediatric patients, use is restricted to Juvenile Idiopathic Arthritis (JIA), typically for those 2 years of age and older, depending on the formulation. The safety and effectiveness for pediatric use in conditions other than JIA have not been established.

Use in elderly patients and those with mild-to-moderate renal or hepatic impairment requires special caution and monitoring, as defined in regulatory labeling.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Melodyn (Meloxicam) has a formally documented interaction profile structured around pharmacodynamic reinforcement and pharmacokinetic interference, as defined in official regulatory documents.

Interaction Scope and Constraints

Property Official Regulatory Statement
Medicinal product categories with documented interactions Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Anticoagulants, Antiplatelet agents, Selective Serotonin Reuptake Inhibitors (SSRIs), Corticosteroids, Methotrexate, Lithium, Diuretics, ACE Inhibitors, Angiotensin II Receptor Blockers (ARBs), Cyclosporine.
Mechanistic basis of interactions Inhibition of Metabolism: Meloxicam metabolism is primarily mediated by CYP2C9. Reduced Clearance: Impaired renal clearance of co-administered drugs like Lithium and Methotrexate. Pharmacodynamic: Additive risk for bleeding/ulceration or antagonistic effects on drug efficacy.
Interaction-related restrictions Co-administration with other NSAIDs and analgesic doses of Aspirin should be avoided. Meloxicam is contraindicated for the relief of peri-operative pain following Coronary Artery Bypass Graft (CABG) surgery.
Population-specific interaction notes Interactions causing renal function deterioration (e.g., with ACE Inhibitors or ARBs) are more clinically significant in the elderly and in patients with impaired renal function.

Official Interaction Statements

  • Bleeding Risk: Melodyn increases the risk of serious bleeding complications when co-administered with Anticoagulants (e.g., Warfarin), Antiplatelet Agents, SSRIs, and Corticosteroids.
  • Exposure Modification: Melodyn can increase the plasma levels of Lithium and Methotrexate due to reduced renal clearance, which elevates the risk of toxicity for those agents.
  • Efficacy Reduction: Melodyn may diminish the antihypertensive or natriuretic effects of medications such as ACE Inhibitors, ARBs, and Diuretics.
  • Dietary Interactions: Consumption of alcohol is officially associated with an increased risk of serious gastrointestinal bleeding. A high-fat meal may result in a 22% increase in peak plasma concentration ( C max).

Mechanism of Action

How Melodyn Works

Melodyn (meloxicam) acts by influencing enzymatic processes within the eicosanoid pathway, which mediates inflammation and nociceptive sensitization. This mechanistic domain is centered on Melodyn's role as a preferential inhibitor of the Cyclo-oxygenase-2 (COX-2) enzyme. By competitively binding to the active site of COX-2, the drug directly suppresses the metabolic conversion of arachidonic acid into pro-inflammatory mediators. This early molecular step influences the initiation of the local inflammatory cascade.

Inhibition of COX-2 leads to the systemic reduction of Prostaglandin E2 (PGE2) and other related prostanoids. This modulation of the prostaglandin synthesis pathway affects physiological processes, including the reduction of vascular permeability and edema formation.

The reduced local concentration of PGE2 directly influences peripheral nociceptive signaling. Prostaglandins act as sensitizers for pain-transmitting nerves (nociceptors); their reduction functionally raises the activation threshold of these neurons. This specific mechanism decreases the sensitization of nociceptive fibers, resulting in a functional reduction of signal transmission to the central nervous system.

Dosage and Administration Information

How Melodyn is Used: Official Administration Guidelines

Melodyn (meloxicam) is used according to established administration guidelines for its available oral and intravenous (IV) forms. These instructions define the proper route, dosage, frequency, and preparation requirements for use in clinical practice.


Official Administration and Dosing

The medicine is generally administered once daily in a single dose across all approved regimens. For oral use in chronic conditions like Osteoarthritis and Rheumatoid Arthritis, the starting dose is typically 7.5 mg once daily, which may be adjusted to a maximum of 15 mg once daily. For acute needs, the intravenous form has a standardized dosage of 30 mg once daily.

Administration Constraint Labeled Instruction Principle
Timing with Food Varies: Guidelines may indicate taking the medicine during a meal, while in other cases it may be taken without regard to the timing of meals
Renal Impairment Maximum daily dose is limited to 7.5 mg for patients on hemodialysis
IV Administration Must be given as a bolus injection over a minimum of 15 seconds

Procedural and Time-Bound Use

Procedurally, liquid forms like the oral suspension require gentle shaking before use. The medicine is used for the shortest duration possible, consistent with the individual treatment plan, and the need for continued therapy should be re-evaluated periodically by a medical professional. Specific adjustments are also applied for pediatric patients with Juvenile Idiopathic Arthritis (JIA), where the dose is weight-based, not to exceed 7.5 mg daily.

If a scheduled dose is missed, it is standard practice not to take a double dose; instead, the subsequent dose should be taken at the usual time.

Recent Clinical Evidence

Melodyn: Recent Clinical Evidence

Evidence for Osteoarthritis (OA)

Research exploring Melodyn for Osteoarthritis is primarily based on large-scale Randomized Controlled Trials (RCTs). These short-term studies were used in research exploring how symptoms change over time in adult patients with OA, typically involving the hip or knee. The trials examined outcomes related to physical discomfort, which included patient-reported outcomes describing perceived discomfort and functional measures. Findings describe measured variations in patient-reported pain intensity and mobility scores compared to placebo. Comparative data show patterns related to symptom variability that were observed in studies comparing Melodyn to other conventional NSAIDs.


Evidence for Rheumatoid Arthritis (RA)

Melodyn was studied in research contexts involving fluctuating symptoms of Rheumatoid Arthritis (RA) in controlled clinical trials involving adult patients with active disease. Studies monitored response using composite measures like the ACR response criteria, which evaluate outcomes describing episodic changes in tender and swollen joint counts. Research describes measurements of changes recorded during the study period, including those related to the duration of morning stiffness. Long-term, open-label extension studies provided continuous data collection for patients treated for up to 18 months.


Evidence in Pediatric and Special Populations

Melodyn was evaluated in dedicated clinical trials involving pediatric patients (ages 2 to 16 years) with Juvenile Idiopathic Arthritis (JIA). Research examined patient outcomes using measures defined by the ACR Pediatric (ACR Pedi) improvement criteria. The volume of evidence specific to children is limited by smaller sample sizes. Additionally, subgroup analyses within adult trials have explored patterns in older adults, but data for certain specific subgroups remain insufficient or uncertain.


Research Consistency and Uncertainties

Across core indications, the research describes patterns observed across multiple short-term, controlled trials. However, evidence for the oral formulation is predominantly derived from settings addressing chronic, fluctuating symptom patterns. Comparative evidence is lacking for the immediate, single-dose management of general acute pain events. Furthermore, long-term effects are not fully established regarding the drug's impact on the overall disease course of chronic inflammatory conditions.

Frequently Asked Questions (FAQ)

Common questions about Melodyn (FAQ)


Q: What is the main difference between Melodyn and other common medicines used for the same purpose?

A: Melodyn belongs to the Nonsteroidal Anti-inflammatory Drug (NSAID) class of medicines. Regulatory documents describe that Melodyn works by preferentially inhibiting the COX-2 enzyme. This specific action helps reduce the body's inflammatory process and manage pain.


Q: Can Melodyn be taken with common over-the-counter pain relievers?

A: Official guidance indicates that combining Melodyn with other NSAIDs, including those available without a prescription like ibuprofen or naproxen, is generally avoided. Official warnings indicate that combining these medicines significantly increases the risk of serious gastrointestinal side effects.


Q: Are there any specific foods or drinks to avoid while on Melodyn?

A: Regulatory documents state that consuming alcohol is associated with an increased risk of serious bleeding in the stomach and intestines. Regulatory information also notes that taking the medication with a high-fat meal can change how the drug is absorbed, potentially increasing its peak concentration in the body.


Q: What are the long-term safety considerations for using Melodyn?

A: Regulatory documents indicate that long-term use of Melodyn, like all NSAIDs, is associated with a greater risk of serious side effects. These risks involve the heart and circulation (thrombotic events) and the stomach and intestines (bleeding or ulcers). Official guidance emphasizes that use must be limited to the lowest effective dose for the shortest possible duration.


Q: Can older adults or seniors use Melodyn?

A: Melodyn is approved for use in adults, which includes older adults and seniors. However, the elderly are at a greater risk for serious side effects, particularly those involving the stomach, intestines, and kidneys. The official product information states that special caution and monitoring may be necessary for this population.


Q: Is Melodyn safe to use during pregnancy or while breastfeeding?

A: Regarding pregnancy, regulatory documents indicate that the medicine must be avoided from the 30th week onward due to the risk of serious harm to the developing fetus. Official documentation also states that the medicine may be found in human milk, and its use during breastfeeding requires caution.


Q: Is Melodyn safe for people with pre-existing heart conditions?

A: The official label contains warnings about an increased risk of serious cardiovascular events, such as heart attack or stroke, with this drug class. Melodyn is contraindicated for use in patients who have severe, uncontrolled heart failure.


Q: Does taking Melodyn affect blood pressure?

A: Studies and official information indicate that taking Melodyn may potentially lead to the onset of new high blood pressure or could cause pre-existing hypertension to worsen. Regulatory guidelines note that blood pressure monitoring is important during treatment.


Q: What are the official warnings about taking Melodyn?

A: The official medication label provides serious warnings regarding potential side effects. These alerts relate to the possibility of serious cardiovascular and circulatory events, as well as the risk of bleeding, ulcers, or perforation in the stomach and intestines. Additionally, warnings exist concerning potential effects on kidney function and liver enzyme levels.


Q: Can I stop taking Melodyn suddenly, or do I need to taper off?

A: Official guidance states that the need for continued therapy should be re-evaluated periodically by a healthcare professional. Any decision to stop the medication, including the method used, must be determined by a healthcare professional.


Q: Why is a specific monitoring (like blood tests) sometimes mentioned with Melodyn?

A: According to official product information, monitoring is advised because the drug can potentially affect liver enzymes and kidney function. This is particularly relevant for long-term use or for individuals with existing impairment. Blood pressure may also be monitored due to the potential risk of new or worsening hypertension.


Q: Does Melodyn have a weight gain risk?

A: Regulatory documents list weight changes, particularly weight gain due to fluid retention (edema), as a possible side effect of this drug class. Fluid retention is a documented side effect that may cause swelling, especially in the legs and feet.


Q: How quickly should I expect to notice any changes after starting Melodyn?

A: After a single dose, the medication reaches its highest concentration in the body within four to six hours. For patients on continuous daily treatment, official information indicates that stable concentrations (known as the steady state) are typically reached after approximately five days.


Q: Is it normal to feel a little dizzy when first taking Melodyn?

A: Official product information states that dizziness, drowsiness, and headache are documented as possible side effects. The official information advises that caution is necessary when performing activities that require concentration if these effects occur.


Q: Is Melodyn considered a controlled substance?

A: No. Melodyn (meloxicam) is a Nonsteroidal Anti-inflammatory Drug (NSAID) and is not classified as a controlled substance under the Controlled Substances Act or equivalent regulation.


Q: What should I do if a side effect seems to be getting worse?

A: If a side effect is severe or persistent, or if symptoms appear that suggest a serious event (such as severe abdominal pain or black/bloody stools), official guidance states that the medication should be discontinued and immediate medical attention should be sought.


Q: Does Melodyn affect my ability to drive or operate machinery?

A: Official patient information indicates that caution is required when driving or operating machinery. This warning is due to the potential for side effects such as dizziness, drowsiness, or blurred vision.


Q: Is it possible to become dependent on Melodyn?

A: No, regulatory information confirms that Melodyn, as an NSAID, is not associated with the risk of addiction or physical dependence. This type of dependence is typically associated with opioid pain medications.


Q: What does 'contraindication' mean in relation to Melodyn?

A: A contraindication is a strict official designation found in regulatory documents. It indicates a specific condition or circumstance, such as a severe allergy or certain heart issues, where the use of the medication is forbidden because the risk of harm is considered to outweigh any potential benefit.


Q: Are there any genetic factors that affect how Melodyn works?

A: Official regulatory documents confirm that the drug is primarily processed (metabolized) in the liver by the enzyme Cytochrome P-450 2C9 (CYP2C9). Genetic variations in the activity of this enzyme can affect how quickly the drug is broken down and eliminated from the body.


Q: Is Melodyn commonly associated with changes in sleep patterns?

A: Changes in sleep patterns, including insomnia (difficulty falling or staying asleep), are documented as uncommon possible side effects of this medicine.


Q: Why is this medication only available by prescription?

A: Medicines are typically available only by prescription when their safe use requires the oversight of a healthcare professional. This is necessary to determine the appropriate dose and to monitor for potentially serious side effects over the course of treatment.


Q: How long does the effect of one dose of Melodyn usually last?

A: The time it takes for half of the drug to be eliminated from the body, known as the mean elimination half-life ( t1/2), ranges from 15 to 20 hours. This duration is consistent with its official once-daily dosing schedule.


Q: Is it true that Melodyn can affect my mood in unexpected ways?

A: Official safety reports indicate that side effects affecting the psychiatric system have been reported. These have included mood changes, as well as confusion and disorientation.


Q: Is Melodyn used for anything other than its main purpose?

A: The drug is formally indicated and approved by regulatory authorities for the signs and symptoms of Osteoarthritis, Rheumatoid Arthritis, and Juvenile Idiopathic Arthritis (JIA) in approved populations. Use for any other purpose is not specified in the regulatory labeling.


Q: Why do some people say Melodyn made them tired?

A: Fatigue and drowsiness are documented as known possible side effects of the medication in official product information.


Q: Does Melodyn affect fertility?

A: As with other NSAIDs, official information indicates that Melodyn may be associated with a reversible delay in ovulation. This effect may make it harder for women of childbearing potential to conceive while taking the drug.


Q: Can taking Melodyn cause stomach upset?

A: Gastrointestinal symptoms, such as stomach pain, nausea, vomiting, and diarrhea, are among the most common side effects reported in clinical trials.


Q: What is the purpose of the boxed warning on Melodyn's label?

A: The Boxed Warning is the most serious alert placed on a drug's label by the FDA. Its purpose is to alert prescribers and patients to the risk of serious or life-threatening events, specifically cardiovascular thrombotic events and serious gastrointestinal adverse events.

How should Melodyn be stored and disposed of?

How to Store and Dispose of Melodyn (Meloxicam Tablets)

Storage Requirements

Melodyn tablets must be stored at a Controlled Room Temperature, specifically 25 C (77 F), with temporary excursions permitted between 15 C and 30 C (59 F and 86 F). The product should not be frozen and must be protected from excessive heat and moisture.

To ensure product stability, the medication must be kept in its original container and the container must remain tightly closed. As a mandatory safety requirement, Melodyn must always be stored out of the sight and reach of children.

Disposal Instructions

Discarding unused or expired Melodyn must follow official regulatory guidance. The preferred method is to utilize a drug take-back program or authorized collection site. The medication must not be disposed of via wastewater (flushing). If a take-back option is unavailable, the product should be mixed with an undesirable substance (such as used coffee grounds) and sealed before being placed in household trash, according to official instructions.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Melodyn found in:

A-Z Index: